COL4A1

COL4A1 is a human gene that encodes type IV collagen alpha 1 chain, a protein which is a precursor to type IV collagen. This protein is a major component of the collagen family, which belongs to the group of structural proteins that provide tensile strength and elasticity to tissues such as the skin, bones, and tendons. Type IV collagen forms a homopolymer sheet that serves as the main structural component of basement membranes, which are specialized extracellular matrices that support epithelial and endothelial cells in various tissues throughout the body.

Mutations in the COL4A1 gene have been associated with various forms of vascular disease, including moyamoya disease, which is a rare condition characterized by progressive narrowing and blockage of the blood vessels in the brain. Some individuals with COL4A1 mutations may also experience cognitive impairment, seizures, and migraine headaches.

The COL4A1 gene is a member of the collagen type IV alpha (COL4A) gene cluster, which is located on the long arm of the q arm of chromosome 13 (13q34). The COL4A1 gene locus spans approximately 8.6 kb of genomic DNA and contains three exons. The COL4A1 protein sequence is composed of 1,549 amino acids.

Insights into the function and regulation of COL4A1 have come from studies on the protein structure and interactions with other basement membrane components. Type IV collagen alpha 1 chain is known to form a triple-helix structure, which is stabilized by interchain hydrogen bonds. This structure is essential for the binding of other molecules such as laminin, perlecan, and nidogen, which interact with the type IV collagen bed to secure basement membrane integrity.

Further research continues to reveal the importance of COL4A1 in maintaining the structural integrity of basement membranes in various tissues. Mutations in this gene have significant implications for diseases affecting the brain, blood vessels, and kidneys.